# 🔬 WIA-BIO-005: Cellular Therapy Standard

[![Version](https://img.shields.io/badge/version-1.0.0-blue.svg)]()
[![License](https://img.shields.io/badge/license-MIT-green.svg)]()
[![Standard](https://img.shields.io/badge/WIA-Standard-purple.svg)]()


> **Standard ID:** WIA-BIO-005
> **Version:** 1.0.0
> **Status:** Active
> **Category:** BIO / Biotechnology & Life Sciences
> **Color:** Teal (#14B8A6)

---

## 🌟 Overview

The WIA-BIO-005 standard defines the framework for cellular therapy development, manufacturing, quality control, and clinical administration. This includes CAR-T cells, stem cell therapies, cell manufacturing protocols, and safety monitoring systems.

**홍익인간 (弘益人間) - Benefit All Humanity** - This standard aims to provide a comprehensive framework for cellular therapies that can treat previously incurable diseases while ensuring patient safety and manufacturing quality.

## 🎯 Key Features

- **Cell Types**: CAR-T cells, NK cells, stem cells, iPSCs, and engineered cell products
- **Manufacturing Processes**: GMP compliance, automation, and scale-up strategies
- **Quality Control**: Cell viability, potency assays, sterility testing, and identity verification
- **Cryopreservation**: Storage protocols, thawing procedures, and stability monitoring
- **Clinical Administration**: Dosing calculations, infusion protocols, and patient preparation
- **Safety Monitoring**: CRS (Cytokine Release Syndrome), neurotoxicity, and adverse event tracking

## 📊 Core Concepts

### 1. Cell Viability Calculation

```
Viability (%) = (Live Cells / Total Cells) × 100
```

Where:
- `Live Cells` = Number of viable cells (typically >85% required)
- `Total Cells` = Total cell count
- Minimum viability: 85% for clinical use

### 2. Cell Expansion Ratio

```
Expansion = (Final Cell Count / Initial Cell Count)
```

Where:
- `Final Cell Count` = Cells after expansion
- `Initial Cell Count` = Starting cell number
- Typical CAR-T expansion: 100-1000×

### 3. Potency Calculation

```
Potency = (Target Cell Killing / Max Killing) × 100%
```

Where:
- `Target Cell Killing` = Observed cytotoxicity
- `Max Killing` = Maximum achievable killing
- Minimum potency: 70% for release

### 4. Dose Calculation

```
Dose (cells/kg) = Total Cells / Patient Weight
```

Where:
- `Total Cells` = Viable cell count
- `Patient Weight` = Weight in kg
- Typical CAR-T dose: 1×10⁶ to 5×10⁶ cells/kg

## 🔧 Components

### TypeScript SDK

```typescript
import {
  calculateDose,
  assessQuality,
  trackManufacturing,
  monitorSafety
} from '@wia/bio-005';

// Calculate patient dose
const dose = calculateDose({
  totalCells: 5e8, // 500 million cells
  patientWeight: 70, // kg
  viability: 92.5 // %
});

// Assess quality metrics
const quality = assessQuality({
  viability: 92.5,
  potency: 85,
  sterility: true,
  endotoxin: 0.3 // EU/mL
});

console.log(quality.passRelease, quality.grade);
```

### CLI Tool

```bash
# Calculate cell dose
wia-bio-005 calc-dose --cells 5e8 --weight 70 --viability 92.5

# Assess quality control
wia-bio-005 assess-quality --viability 92.5 --potency 85 --endotoxin 0.3

# Track manufacturing batch
wia-bio-005 track-batch --batch CT-2024-001 --stage expansion

# Monitor patient safety
wia-bio-005 monitor-safety --patient PT-001 --day 7
```

## 📚 Documentation

| Document | Description |
|----------|-------------|
| [WIA-BIO-005-v1.0.md](./spec/WIA-BIO-005-v1.0.md) | Complete specification with protocols |
| [TypeScript SDK](./api/typescript/) | Full TypeScript implementation |
| [CLI Tool](./cli/wia-bio-005.sh) | Command-line interface |

## 🚀 Quick Start

### Installation

```bash
# Clone repository
git clone https://github.com/WIA-Official/wia-standards.git
cd wia-standards/standards/cellular-therapy

# Run installation script
./install.sh

# Verify installation
wia-bio-005 --version
```

### TypeScript Usage

```bash
# Install via npm
npm install @wia/bio-005

# Or yarn
yarn add @wia/bio-005
```

```typescript
import { CellularTherapySDK } from '@wia/bio-005';

const sdk = new CellularTherapySDK();

// Calculate dose for CAR-T therapy
const result = sdk.calculateDose({
  cellType: 'CAR-T',
  totalCells: 3e8,
  patientWeight: 65,
  viability: 90
});

console.log(`Dose: ${result.dose.toExponential()} cells/kg`);
console.log(`Pass criteria: ${result.withinRange}`);
```

## 🧬 Cell Types

| Type | Description | Typical Use |
|------|-------------|-------------|
| CAR-T | Chimeric Antigen Receptor T cells | Cancer immunotherapy |
| CAR-NK | Modified Natural Killer cells | Solid tumors |
| MSC | Mesenchymal Stem Cells | Regenerative medicine |
| iPSC | Induced Pluripotent Stem Cells | Cell replacement |
| TIL | Tumor Infiltrating Lymphocytes | Melanoma, solid tumors |

## 🏭 Manufacturing Standards

### GMP Requirements

1. **Cleanroom**: ISO 5 (Class 100) for critical steps
2. **Personnel**: Qualified operators with aseptic training
3. **Equipment**: Validated bioreactors and cell processors
4. **Documentation**: Batch records, deviations, and CAPAs
5. **Quality Control**: In-process and final release testing

### Quality Metrics

| Parameter | Acceptance Criteria | Method |
|-----------|---------------------|---------|
| Viability | ≥85% | Trypan Blue or Flow Cytometry |
| Potency | ≥70% | Cytotoxicity Assay |
| Sterility | No growth | USP <71> |
| Endotoxin | <5 EU/kg dose | LAL Assay |
| Identity | Positive for target marker | Flow Cytometry |
| Purity | ≥80% target cells | Flow Cytometry |

## ⚠️ Safety Monitoring

### Cytokine Release Syndrome (CRS)

Grading scale:
- **Grade 1**: Fever only
- **Grade 2**: Hypotension and/or hypoxia requiring intervention
- **Grade 3**: Grade 2 symptoms requiring aggressive intervention
- **Grade 4**: Life-threatening symptoms

Management: Tocilizumab, corticosteroids, supportive care

### Immune Effector Cell-Associated Neurotoxicity (ICANS)

Monitoring: Daily neurological assessments for 10 days post-infusion

Assessment: ICE (Immune Effector Cell-Associated Encephalopathy) score

## 🌐 WIA Integration

This standard integrates with:
- **WIA-INTENT**: Intent-based therapy selection
- **WIA-OMNI-API**: Universal healthcare API
- **WIA-HEALTH**: Patient health records
- **WIA-PHARMA**: Drug interaction monitoring

## 📖 Use Cases

1. **Cancer Immunotherapy**: CAR-T for B-cell malignancies, multiple myeloma
2. **Regenerative Medicine**: Stem cells for cartilage repair, cardiac regeneration
3. **Autoimmune Diseases**: Regulatory T cells for immune modulation
4. **Genetic Disorders**: Gene-edited cells for sickle cell disease, beta-thalassemia
5. **Anti-Aging**: Cellular rejuvenation therapies

## 🤝 Contributing

Contributions welcome! Please see our [Contributing Guide](https://github.com/WIA-Official/wia-standards/CONTRIBUTING.md).

## 📄 License

MIT License - see [LICENSE](https://github.com/WIA-Official/wia-standards/LICENSE)

## 🔗 Links

- **Website**: [wiastandards.com](https://wiastandards.com)
- **GitHub**: [github.com/WIA-Official/wia-standards](https://github.com/WIA-Official/wia-standards)
- **Documentation**: [docs.wiastandards.com](https://docs.wiastandards.com)
- **Certification**: [cert.wiastandards.com](https://cert.wiastandards.com)

---

**홍익인간 (弘益人間) · Benefit All Humanity**

*WIA - World Certification Industry Association*
*© 2025 SmileStory Inc. / WIA*
*MIT License*

---

**홍익인간 (弘益人間) - Benefit All Humanity** 🌍
